Product info
EuroProxima Zeranol Spiking Solution Art. No. 5081ZERANSP
Order product
Please choose a country to find your local sales partner.
If your country is not available in this list please contact us directly at sales@r-biopharm.com
R-Biopharm France | Tunisia Phone: +33 (0) 4 78 64 32 00
standard@r-biopharm.fr
R-Biopharm France | Algeria Phone: +33 (0) 4 78 64 32 00
standard@r-biopharm.fr
R-Biopharm France | Morocco Phone: +33 (0) 4 78 64 32 00
standard@r-biopharm.fr
R-Biopharm Inc. Phone: +1 (0) 877 789 3033
info@r-biopharm.com
R-Biopharm Rhône Ltd. Phone: +44 (0) 14 19 45 29 24
info@r-biopharmrhone.com
R-Biopharm AG - Switzerland Phone: +41 (0) 26 67 00 157
r.blaettler@r-biopharm.ch
R-Biopharm España S.A. Sociedad Unipersonal Phone: +34 902 903 355
info@r-biopharm.es
R-Biopharm Nederland B.V. Phone: +31 (0) 26 - 36 30 364
info@r-biopharm.nl
R-Biopharm Italia srl Phone: +39 (0) 29 82 33 330
info@r-biopharm.it
R-Biopharm Neugen Pvt. Ltd. Phone: +91 (0) 40-69027800
info@r-biopharm.in
R-Biopharm France Phone: +33 (0) 4 78 64 32 00
standard@r-biopharm.fr
R-Biopharm China Phone: +86 (0) 10 – 84 58 32 18 -215
info@r-biopharm.cn
R-Biopharm Clinical Canada Phone: +1 (519) 203-2040
orders@r-biopharm.ca
R-Biopharm Brasil Phone: +55 (0) 19 3305 7351
vendas@r-biopharmbrasil.com.br
R-Biopharm France Phone: +33 (0) 4 78 64 32 00
standard@r-biopharm.fr
R-Biopharm Nederland B.V. Phone: +31 (0) 26 - 36 30 364
info@r-biopharm.nl
R-Biopharm AG - Austria Phone: +49 (0) 61 51 – 8102 0
s.weiss@r-biopharm.de
R-Biopharm Australia Phone: +61 (0) 2 9668 0600
p.hill@labdiagnostics.com.au
R-Biopharm Latinoamérica S.A. Phone: +54 (0) 11 - 45 89 07 77
info@r-biopharmlat.com.ar
Request information
Intended use EuroProxima Zeranol Spiking Solution can be used for the production of positive control samples suitable for the validation (e.g. determination of the recovery rate) of the EuroProxima Zeranol (Art. No. 5081ZERAN).
Dear customers,
we now provide the documents for our products in an electronic format which include the Instructions for Use (IFU), Safety Data Sheets (SDS), Application notes and the Certificate of Analysis (CoA).
For batches placed on the market after 1st of January 2024, you can find our documents on the eIFU portal
eifu.r-biopharm.com/RBNL .
Specifications
Art. No 5081ZERANSP Test format Concentration: 20 ng/ml (ppb),
